Skip to main content

Table 1 Clinical Characteristics of patients for metagenomic sequence

From: Exploration of lung mycobiome in the patients with non-small-cell lung cancer

Feature

NSCLC patients

Non-NSCLC Patients

Patients(n = 38)

24(63.2%)

14(36.8%)

Genders(n = 38) p = 0.929

Male

12

Male

8

Female

12

Female

6

Age(n = 38) p = 0.125

 ≤ 50

9

 ≤ 50

7

 > 50

15

 > 50

7

Smoking status(n = 38) p = 1.000

Smoker

4

Smoker

2

Non-smoker

20

Non-smoker

12

TNM staging(n = 22)

T1aN0M0

2

 

T1bN0M0

T1cN0M0

T2aN0M0

T2bN1M0

T3N1M0

T4N0M0

Tia

7

1

8

1

1

1

1

  1. All patients are immunocompetent in the cohort